On Sept. 7, 2017, Food and Drug Administration (FDA) released an announcement at local time that after systematic review on existing scientific evidence, FDA plans to allow apply foods of peanuts from four to ten months with “health claim” to infants suffering serious eczema and egg allergy so as to reduce allergic risks of children under five. The “health claim” is attached with restricted language or disclaimer so as to accurately deliver scientific evidence support claims. FDA performs enforcement power for the use of “health claim”.